−2.45USD
−95.73 MUSD
26.94 M
About Mind Medicine (MindMed) Inc.
Sector
CEO
Robert Barrow
Headquarters
New York
Website
Employees (FY)
57
Founded
2019
ISIN
CA60255C8850
FIGI
BBG00F13HYQ7
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MNMD is 9.53 USD — it has decreased by 3.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mind Medicine (MindMed) Inc. stocks are traded under the ticker MNMD.
Mind Medicine (MindMed) Inc. is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
MNMD stock is 5.89% volatile and has beta coefficient of 2.34. Check out the list of the most volatile stocks — is Mind Medicine (MindMed) Inc. there?
One year price forecast for Mind Medicine (MindMed) Inc. has a max estimate of 75.00 USD and a min estimate of 16.00 USD.
MNMD earnings for the last quarter are −0.45 USD whereas the estimation was −0.65 USD which accounts for 31.22% surprise. Estimated earnings for the next quarter are −0.46 USD. See more details about Mind Medicine (MindMed) Inc. earnings.
Yes, you can track Mind Medicine (MindMed) Inc. financials in yearly and quarterly reports right on TradingView.
MNMD stock has fallen by 2.66% compared to the previous week, the month change is a 3.14% rise, over the last year Mind Medicine (MindMed) Inc. has showed a 166.20% increase.
MNMD net income for the last quarter is −23.86 M USD, while the quarter before that showed −17.92 M USD of net income which accounts for −33.15% change. Track more Mind Medicine (MindMed) Inc. financial stats to get the full picture.
Today Mind Medicine (MindMed) Inc. has the market capitalization of 268.39 M, it has increased by 10.56% over the last week.
No, MNMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MNMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mind Medicine (MindMed) Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 57.00 employees. See our rating of the largest employees — is Mind Medicine (MindMed) Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mind Medicine (MindMed) Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mind Medicine (MindMed) Inc. stock shows the buy signal. See more of Mind Medicine (MindMed) Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Mind Medicine (MindMed) Inc. future price: according to them, MNMD price has a max estimate of 75.00 USD and a min estimate of 16.00 USD. Read a more detailed Mind Medicine (MindMed) Inc. forecast: see what analysts think of Mind Medicine (MindMed) Inc. and suggest that you do with its stocks.